CIBC Bancorp USA’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
CIBC Bancorp USA's ELV Position: Q2 2026 in Review
CIBC Bancorp USA reduced its Elevance Health (ELV) stake by 18% in Q2 2026, selling an estimated $30.1M and leaving 381,188 shares worth $147M. The position accounts for 0.18% of the portfolio, ranked #134.
CIBC Bancorp USA first reported a position in ELV in Q3 2025 and has held it in 3 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- CIBC Bancorp USA held 381,188 shares of Elevance Health worth $147M as of Q2 2026.
- CIBC Bancorp USA sold 81,239 Elevance Health shares in Q2 2026, an estimated $30.1M.
- Elevance Health made up 0.18% of CIBC Bancorp USA's portfolio in Q2 2026, its #134 holding.
- CIBC Bancorp USA first reported a position in Elevance Health in Q3 2025 and has held it in 3 quarters since.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.